Regulation - Russia

Filter

Current filters:

Russia

Popular Filters

Russian government plans to cut number of generics; controls on MNCs

Russian government plans to cut number of generics; controls on MNCs

23-06-2014

The number of drugs in the Russian market will decline significantly over the next several years, due…

GenericsPricingRegulationRussia

Biocad’s AcellBia is first MAb biosimilar approved by Russia’s Ministry of Health

15-05-2014

A biosimilar of Swiss drug major Roche’s MabThera (rituximab), to be marketed under the trade name…

AcellBiaBiocadBiosimilarsGenericsMabTheraOncologyRegulationRocheRussia

Russia to postpone transfer of domestic pharma production to GMP-standards until 2016

21-02-2014

The Russian government has decided to postpone until 2016 the requirement of domestic pharmaceutical…

Eastern EuropePharmaceuticalProductionRegulationRussia

Russian government continues to create barriers for foreign pharma business

Russian government continues to create barriers for foreign pharma business

23-12-2013

The Russian government continues to create barriers for the business of foreign pharmaceutical producers…

Eastern EuropePharmaceuticalProductionRegulationRussia

Russia, Ukraine and the Baltic states increasing in importance on the contract manufacturing market

Russia, Ukraine and the Baltic states increasing in importance on the contract manufacturing market

11-12-2013

Russia seems to be an attractive country for pharmaceutical contract manufacturing, chiefly because of…

Asia-PacificChinaEastern EuropeGenericsIndiaProductionRegulationRussiaUkraine

Company Spotlight

ImmunoGen

ImmunoGen

Back to top